| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/24/2004 | CN1484644A Novel 7-azaindoles use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 03/24/2004 | CN1484537A Pharmacentical preparation for douches and/or irrigations of natural or puthological cavities in human body |
| 03/24/2004 | CN1484532A Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens |
| 03/24/2004 | CN1484526A Perturbed membrane-binding compounds |
| 03/24/2004 | CN1484494A Pesticidal and antiparasitic compositions |
| 03/24/2004 | CN1483736A Immunogen for producing vaccine or medicine to treat hepatitis B, its preparation process and use |
| 03/24/2004 | CN1483477A Vaccin composition, preparation method and use thereof |
| 03/24/2004 | CN1483476A Process for preparing antitoxin toxinicide |
| 03/24/2004 | CN1483466A Polygonum capitatum extract and medicinal composition preparation thereof |
| 03/24/2004 | CN1483463A Anti-virus Chinese medicine composition and preparation process thereof |
| 03/24/2004 | CN1483451A Method for extracting 50% aloetin |
| 03/24/2004 | CN1483442A Traditional Chinese medicine for treating virus hepatitis and preparation process thereof |
| 03/24/2004 | CN1483440A Fish medicine for preventing and controlling fish fulminant diseases and preparation process thereof |
| 03/24/2004 | CN1483431A Pill for treating hepatitis B |
| 03/24/2004 | CN1483413A Medicinal composition for treationg virus infention of rlavivirus family, set group and packaged products |
| 03/24/2004 | CN1483404A Broad-spectrum antivenerenl external used medicine |
| 03/24/2004 | CN1483403A Liquid soft capsule containing brufen and pseudoephedrine hydrochloride |
| 03/24/2004 | CN1483398A Vegetable oil fatty milk oral or injection preparation |
| 03/24/2004 | CN1142996C Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 03/24/2004 | CN1142941C Cells bearing CD4 decoy receptors and related molecules and methods |
| 03/24/2004 | CN1142937C Antibacterial cephalosporins |
| 03/24/2004 | CN1142933C Heterocycilc compounds for inhibition of gastric acid secretion, processes for their prepn. and pharmaceutical composition thereof |
| 03/24/2004 | CN1142788C Chinese medicine preparation for treating infant pulmonitis and dyspneic cough |
| 03/24/2004 | CN1142772C Lipophilic microparticles containing protein drug or antigen and formulation comprising same |
| 03/23/2004 | US6710209 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 03/23/2004 | US6710163 Compounds that bind single-stranded dna and rna strands to form stable hybrids; bind complementary single-stranded dna and rna strands more strongly than corresponding dna |
| 03/23/2004 | US6710090 Inhibitory or blocking agents of molecular generating and/or inducing functions |
| 03/23/2004 | US6710075 Compounds having a cyclopentabenzofuran core shown to exhibit potent cytotoxic and cytostatic effects on cancer cell growth and viability |
| 03/23/2004 | US6710067 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/23/2004 | US6710065 Benzimidazole derivatives and their use for the treatment of cancer or a viral infection |
| 03/23/2004 | US6710054 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/23/2004 | US6710049 Fungicides for aids, diabetic patients |
| 03/23/2004 | US6710045 Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides (IV) |
| 03/23/2004 | US6710034 5-O-mycaminosyltylonide derivatives |
| 03/23/2004 | US6710029 Dehydrodidemnin B |
| 03/23/2004 | US6709851 Stabilization of helicobacter urease |
| 03/23/2004 | US6709663 Topical emulsion; quaternary ammonium salt emulsifier |
| 03/23/2004 | US6709660 Meningococcal antigens |
| 03/23/2004 | US6709656 Polyclonal and/or monoclonal immunoglobulin immunization |
| 03/23/2004 | US6709649 RANTES derived peptides with anti-HIV activity |
| 03/23/2004 | CA2350074C Aerosols comprising nanoparticle drugs |
| 03/18/2004 | WO2004023138A1 Method of screening remedy for aids |
| 03/18/2004 | WO2004022761A1 Retroviral vector and stable packaging cell lines |
| 03/18/2004 | WO2004022729A1 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 03/18/2004 | WO2004022727A1 Probiotic bacterium: lactobacillus fermentum |
| 03/18/2004 | WO2004022716A2 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 03/18/2004 | WO2004022657A2 Increasing of the resorption of substances via skin and mucous membranes |
| 03/18/2004 | WO2004022585A1 Hbv precore protein capable of forming particles |
| 03/18/2004 | WO2004022582A1 Peptidomimetic drugs |
| 03/18/2004 | WO2004022569A1 Akt inhibitors, pharmaceutical compositions, and uses thereof |
| 03/18/2004 | WO2004022568A1 Aryl-ethanolamine derivatives as antiviral agents |
| 03/18/2004 | WO2004022567A1 Heteroaryl-ethanolamine derivatives as antiviral agents |
| 03/18/2004 | WO2004022566A1 4-OXO-4,7-DIHYDROTHIENO[2,3-b]PYRIDINE-5-CARBOXAMIDES AS ANTIVIRAL AGENTS |
| 03/18/2004 | WO2004022563A1 Benzotriazabicyclic derivatives and use thereof as beta-lactamase inhibitors and anti-bacterial agents |
| 03/18/2004 | WO2004022557A1 Novel benzonaphthyridines |
| 03/18/2004 | WO2004022556A1 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist |
| 03/18/2004 | WO2004022553A1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING IκB KINASE |
| 03/18/2004 | WO2004022128A2 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 03/18/2004 | WO2004022124A1 Medical device having hydration inhibitor |
| 03/18/2004 | WO2004022092A2 Flagellin peptides as adjuvants for vaccines |
| 03/18/2004 | WO2004022084A1 A method of modulating cellular activity and molecules for use therein |
| 03/18/2004 | WO2004022048A1 Fosfomycin and n-acetylcysteine for the treatment of biofilms caused by escheric ia coli and other pathogens of the urinary tract |
| 03/18/2004 | WO2004022041A2 Treatment of non-allergic rhinitis by means of selective phosphodiesterase-4 inhibitors |
| 03/18/2004 | WO2004022032A2 Pharmaceutical dosage form comprising a sulfite compound |
| 03/18/2004 | WO2004021969A2 Non-nucleoside reverse transcriptase inhibitors |
| 03/18/2004 | WO2004021968A2 Solution for ungual application |
| 03/18/2004 | WO2004011477A3 6,11-4-carbon bridged ketolides |
| 03/18/2004 | WO2004009583A3 Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor |
| 03/18/2004 | WO2004007489A3 Antibacterial substituted cyanomethyl (ene) piperidinophenyl oxazolidinones, process or their preparation, and pharmaceutical compositions containing them |
| 03/18/2004 | WO2004007488A3 Antimicrobial oxazolidinones, process of their preparation, and pharmaceutical compositions containing them |
| 03/18/2004 | WO2004006952A3 Therapeutic tuberculosis vaccines |
| 03/18/2004 | WO2004006851A3 Mycoplasma gallisepticum formulation |
| 03/18/2004 | WO2004005286A3 Viral inhibitors |
| 03/18/2004 | WO2003099192A3 Bis-aromatic alkanols |
| 03/18/2004 | WO2003097608A3 Opioid and opioid-like compounds and uses thereof |
| 03/18/2004 | WO2003097576A3 Diamino-functional chalcones |
| 03/18/2004 | WO2003094919A3 Novel crystalline forms of gatifloxacin |
| 03/18/2004 | WO2003093290A3 Nucleoside derivatives for treating hepatitis c virus infection |
| 03/18/2004 | WO2003090744A8 Antibacterial compositions comprising metal phthalocyanine analogues |
| 03/18/2004 | WO2003086442A3 Ophthalmic, pharmaceutical and other healthcare preparations with naturally occuring plant compounds, extracts and derivatives |
| 03/18/2004 | WO2003084936A3 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological |
| 03/18/2004 | WO2003070750A3 Rna interference mediated inhibition of hepatitis c virus |
| 03/18/2004 | WO2003054197A3 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 03/18/2004 | WO2003028630A3 Methods and compositions for modulating interleukin-21 receptor activity |
| 03/18/2004 | WO2003015809A3 Antimicrobial cationic peptides and formulations thereof |
| 03/18/2004 | WO2003011298A8 Antibacterial oxazinones and methods for their use and synthesis |
| 03/18/2004 | WO2003007869A3 Immunogenic compositions containing antigens, gene vectors and adjuvants-loaded biodegradable microspheres |
| 03/18/2004 | WO2002080856A3 Triaza compound immunoregulatory agents |
| 03/18/2004 | WO2002078516A3 Compositions and methods for the therapy and diagnosis of cancer |
| 03/18/2004 | US20040054182 Antiinflammatory agents; rheumatic diseases; antiallergens; skin disorders; anticancer agents; antidiabetic agents |
| 03/18/2004 | US20040054172 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids |
| 03/18/2004 | US20040054155 Oligonucleotide compositions with enhanced efficiency |
| 03/18/2004 | US20040054149 Modified proteolytic enzyme for treatment of osteoarthritis |
| 03/18/2004 | US20040054145 Truncated cd200 |
| 03/18/2004 | US20040054139 Chimeric genetically engineered DNA viral protein for use in immunotherapy and vaccine development |
| 03/18/2004 | US20040054137 Chimeric protein for diagnosis and treatment of cancers and infections; immunotherapy |
| 03/18/2004 | US20040054136 Comprises nucleotide sequences coding transporter associated with antigen processing-like polypeptides (human TAP-like) for diagnosis and treatment of infection, tumors and autoimmune diseases |
| 03/18/2004 | US20040054015 Gel for treatment of skin diseases |
| 03/18/2004 | US20040054001 For preparing a pharmaceutical composition for treating diseases that may be influenced by NF-kappaB, particularly psoriasis |
| 03/18/2004 | US20040053993 Compositions of tocol-soluble therapeutics |